SiriusPoint (SPNT) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 Nov, 2026Executive summary
Q3 core combined ratio was 90.1%; Operating ROE was 17.6% in Q3 and 15.8% for 9M, above the 12%–15% across-cycle target.
Q3 Operating net income was $103m and Operating EPS rose 19% to $0.88; 9M Operating net income was $273m and Operating EPS was $2.29.
RiverStone LPT covers substantially all remaining run-off reserves and is expected to release over $200m of capital, reduce legacy volatility and leave run-off exposures at de minimis levels, pending approvals.
Financial highlights
Q3 Core GWP rose 14% to $991m; NWP increased 2% to $679m and net earned premium rose 19% to $767.6m.
Q3 Core underwriting income increased 9% to $76m; net services fee income was $12m, up 44% for go-forward MGAs.
9M Core GWP rose 7% to $2,975.9m; Core underwriting income increased 22% to $201.8m, while NWP declined 1% to $2,085m.
Q3 revenue was $867.6m and net income available to common shareholders was $86.8m; 9M revenue was $2,386.3m and common net income was $255.0m, including a $25.2m Arcadian sale gain.
Diluted book value per share excluding AOCI increased 4% sequentially and 12% YTD to $20.21.
Outlook and guidance
Across-cycle ROE target remains 12%–15%; management expects core operating ROE to meet or exceed the range following the LPT.
Q4 A&H premiums are expected to return to low-single-digit growth; Specialty P&C premiums may be modestly lower YoY, with growth expected to resume in 2027.
2027 pipeline is encouraging, particularly in MGA global programs and A&H; further growth and planning details are planned with full-year results.
RiverStone LPT closing is targeted for Dec. 31, 2026, subject to regulatory approvals and customary conditions; Q1 is possible if conditions are met later.
Latest events from SiriusPoint
- FY23 turnaround delivered $338.8m net income and 16.2% ROE.SPNT
Q4 2023 - Q2 and HY 2026 results show strong ROE, disciplined growth, and robust capital position.SPNT
Investor presentation - Q2 2026 net income rose to $69M, with 13.8% ROE and 15% Insurance & Services premium growth.SPNT
Q2 2026 - Q1 2026 net income hit $102.3M, core combined ratio 88.9%, and $242M capital returned.SPNT
Q1 2026 - 2026 AGM features director elections, say-on-pay, auditor reappointment, and new share plan.SPNT
Proxy filing - FY25 net income up 141%, 16% premium growth, and 16.2% ROE with major capital actions.SPNT
Q4 2025 - Q3 2024 saw improved underwriting, strong investment income, and robust capital strength.SPNT
Q3 2024 - Q2 net income $109.9M, book value up 7.2%, and share buyback authorization at $306.3M.SPNT
Q2 2024 - Q1 2025 saw strong premium growth, stable earnings, and upgraded ratings despite catastrophe losses.SPNT
Q1 2025